Zobrazeno 1 - 10
of 907
pro vyhledávání: '"Pugsley, MK"'
Autor:
Chaudhary KW; Bristol Myers Squibb, New Brunswick, New Jersey, USA., Clancy CE; Department of Physiology and Membrane Biology, University of California Davis, Davis, California, USA., Yang PC; Department of Physiology and Membrane Biology, University of California Davis, Davis, California, USA., Pierson JB; HESI, Washington, DC, USA., Goldin AL; University of California, Irvine, Irvine, California, USA., Koerner JE; Independent, San Diego, California, USA., Wisialowski TA; Pfizer, Groton, Connecticut, USA., Valentin JP; UCB Biopharma SRL, Braine-l'Alleud, Belgium., Imredy JP; Merck & Co., Inc., Rahway, New Jersey, USA., Lagrutta A; Merck & Co., Inc., Rahway, New Jersey, USA., Authier S; Charles River Laboratories, Laval, Quebec, Canada., Kleiman R; Clario, Philadelphia, Pennsylvania, USA., Sager PT; Stanford University, Palo Alto, California, USA., Hoffmann P; Independent, Beaufort, South Carolina, USA., Pugsley MK; Cytokinetics, South San Francisco, California, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Dec; Vol. 17 (12), pp. e70098.
Autor:
Friedrichs GS; Novartis Biomedical Research, 1 Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: greg.friedrichs@novartis.com., Abernathy MM; Eli Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA., Ackley D; Eli Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA., Clark M; Ability Biologics, 3 Place Ville-Marie Suite 400, Montréal, Québec H3B 4W8, Canada., DaSilva JK; Pfizer Research and Development, 445 Eastern Point Rd Groton, CT 06340, USA., Foley CM; Abbvie Inc, North Chicago, IL, 60064, USA., Greiter-Wilke A; Roche Innovation Center Basel, Grenzacherstr. 124, CH 4070 Basel, Switzerland., Henderson KA; Amgen Inc., Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA., Kremer JJ; Novartis BioMedical Research, 220 Massachusetts Avenue, Cambridge, MA 02139, USA., Morimoto BH; Alto Neuroscience, Inc. 369 S San Antonio Rd, Los Altos CA 94022, USA., Paglialunga S; Celerion, 2420 W Baseline Rd, Tempe, AZ 85283, USA., Pugsley MK; Cytokinetics, 350 Oyster Point Blvd, South San Francisco, CA 94080, USA., Regan CP; Merck & Co., Inc., West Point, PA 19486, USA., Rossman EI; GSK, 1250 Collegeville Avenue, Collegeville, PA 19426, USA., Segretti JA; Abbvie Inc, North Chicago, IL, 60064, USA., Traebert M; Novartis BioMedical Research, Postfach, 4002 Basel, Switzerland., Vargas HM; Amgen Inc., Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA., Wisialowski TA; Pfizer Research and Development, 445 Eastern Point Rd Groton, CT 06340, USA.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2024 Nov; Vol. 153, pp. 105706. Date of Electronic Publication: 2024 Sep 16.
Autor:
Bonet-Luz E; Department of Mathematics, University of Surrey, Guildford, Surrey GU2 7XH, UK., Nandi M; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, Stamford Street, London SE1 9NH, UK. Electronic address: Manasi.Nandi@kcl.ac.uk., Christie MI; Akranim Ltd., 90/92 King Street, Maidstone, Kent ME14 1BH, UK. Electronic address: mark.christie@akranim.co.uk., Doyle J; DSI Harvard Bioscience, St. Paul, MN 55101, USA. Electronic address: jdoyle@harvardbioscience.com., Pierson JB; Health and Environmental Life Sciences, Washington, DC 20005, USA. Electronic address: jpierson@hesiglobal.org., Pugsley MK; Department of Toxicology & Safety Pharmacology, Cytokinetics, LLC, South San Francisco, CA 94080, USA. Electronic address: mpugsley@cytokinetics.com., Vargas HM; Translational Safety & Bioanalytical Sciences, Amgen, Inc., Thousand Oaks, CA 91320, USA. Electronic address: hvargas@amgen.com., Aston PJ; Department of Mathematics, University of Surrey, Guildford, Surrey GU2 7XH, UK. Electronic address: P.Aston@surrey.ac.uk.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 Sep-Oct; Vol. 129, pp. 107546. Date of Electronic Publication: 2024 Jul 26.
Autor:
Pugsley MK; Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA 94080, United States of America. Electronic address: mpugsley@cytokinetics.com., Winters BR; Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA 94080, United States of America., Koshman YE; Safety Pharmacology, Abbvie, North Chicago, IL 60064, United States of America., Authier S; Charles River Laboratories, Laval, QC H7V 4B3, Canada., Foley CM; Safety Pharmacology, Abbvie, North Chicago, IL 60064, United States of America., Hayes ES; BioCurate Pty Ltd, Carlton, Victoria 3053, Australia., Curtis MJ; Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London SE17EH, UK.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 Jul-Aug; Vol. 128, pp. 107533. Date of Electronic Publication: 2024 Jun 28.
Autor:
Boulay E; GREPAQ (Groupe de Recherche en Pharmacologie Animale du Québec), Université de Montréal, Saint-Hyacinthe, QC, Canada.; Charles River Laboratories, Laval, QC, Canada., Troncy E; GREPAQ (Groupe de Recherche en Pharmacologie Animale du Québec), Université de Montréal, Saint-Hyacinthe, QC, Canada., Jacquemet V; Département de Pharmacologie et Physiologie, Université de Montréal, Faculté de Médecine, Montréal, QC, Canada.; Centre de Recherche, Hôpital du Sacré-Cœur, Montréal, QC, Canada.; Institut de Génie Biomédical, Université de Montréal, Montréal, QC, Canada., Huang H; Charles River Laboratories, Laval, QC, Canada., Pugsley MK; Toxicology & Safety Pharmacology, Cytokinetics, San Francisco, CA, USA., Downey AM; Charles River Laboratories, Laval, QC, Canada., Venegas Baca R; Charles River Laboratories, Laval, QC, Canada., Authier S; GREPAQ (Groupe de Recherche en Pharmacologie Animale du Québec), Université de Montréal, Saint-Hyacinthe, QC, Canada.; Charles River Laboratories, Laval, QC, Canada.
Publikováno v:
International journal of toxicology [Int J Toxicol] 2024 Jul-Aug; Vol. 43 (4), pp. 357-367. Date of Electronic Publication: 2024 Mar 13.
Autor:
Pierson JB; Health and Environmental Sciences Institute, Washington, DC, USA., Berridge B; B2 Pathology Solutions LLC, Cary, NC, USA., Blinova K; Food and Drug Administration, Silver Spring, MD, USA., Brooks MB; Comparative Coagulation Section, Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY, USA., Eldridge S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., O'Brien CE; Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cobrien@hesiglobal.org., Pugsley MK; Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA, USA., Schultze AE; Pathology, Lilly Research Laboratories, Indianapolis, IN, USA., Smith G; Clyde Biosciences Ltd, Newhouse, UK; University of Glasgow, Scotland, UK., Stockbridge N; Food and Drug Administration, Silver Spring, MD, USA., Valentin JP; UCB Biopharma SRL, Development Science, Non-Clinical Safety Evaluation, Braine l'Alleud, Belgium., Vicente J; Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 May-Jun; Vol. 127, pp. 107511. Date of Electronic Publication: 2024 May 06.
Autor:
De Alwis D; Health and Environmental Sciences Institute, Washington, DC 20005, USA., Foley CM; Abbvie Inc., North Chicago, IL 60064, USA. Electronic address: Michael.Foley@abbvie.com., Herman E; National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: eugene.herman2@nih.gov., Hill AP; Victor Chang Cardiac Research Institute, Sydney, NSW, Australia. Electronic address: a.hill@victorchang.edu.au., Hoffmann PK; Cat Island, Beaufort, SC 29907, USA., Kanda Y; National Institute of Health Sciences (NIHS), Kawasaki, Japan. Electronic address: kanda@nihs.go.jp., Kaushik E; Takeda Pharmaceuticals Company Ltd., Cambridge, MA 02139, USA. Electronic address: Emily.Kaushik@takeda.com., Pierson J; Health and Environmental Sciences Institute, Washington, DC 20005, USA. Electronic address: jpierson@hesigloba.org., Puglisi R; Health and Environmental Sciences Institute, Washington, DC 20005, USA. Electronic address: rpuglisi@hesiglobal.org., Shi H; Bristol-Myers Squibb Co., Princeton, NJ 08543, USA. Electronic address: hong.shi@bms.com., Yang X; RTI International, Washington, DC 20005, USA. Electronic address: xyang@rti.org., Pugsley MK; Cytokinetics, South San Francisco, CA 94080, USA. Electronic address: mpugsley@cytokinetics.com.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 May-Jun; Vol. 127, pp. 107507. Date of Electronic Publication: 2024 Apr 16.
Autor:
Orciani C; Charles River, Laval, QC, Canada., Ballesteros C; Charles River, Laval, QC, Canada., Troncy E; GREPAQ, Faculté de Médecine Vétérinaire, Universite de Montreal, Saint Hyacinthe, QC, Canada., Berthome C; Centre Veterinaire DMV, QC, Canada., Bujold K; Charles River, Laval, QC, Canada., Bennamoune N; Charles River, Laval, QC, Canada., Sparapani S; Charles River, Laval, QC, Canada., Pugsley MK; Cytokinetics, South San Francisco, CA, United States., Paquette D; GREPAQ, Faculté de Médecine Vétérinaire, Universite de Montreal, Saint Hyacinthe, QC, Canada., Boulay E; Charles River, Laval, QC, Canada.; GREPAQ, Faculté de Médecine Vétérinaire, Universite de Montreal, Saint Hyacinthe, QC, Canada., Authier S; Charles River, Laval, QC, Canada.; GREPAQ, Faculté de Médecine Vétérinaire, Universite de Montreal, Saint Hyacinthe, QC, Canada.
Publikováno v:
International journal of toxicology [Int J Toxicol] 2024 Mar-Apr; Vol. 43 (2), pp. 123-133. Date of Electronic Publication: 2023 Dec 08.
Autor:
Pugsley MK; Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA 94080, USA. Electronic address: mpugsley@cytokinetics.com., Koshman YE; Safety Pharmacology, Abbvie, North Chicago, IL 60064, USA., Foley CM; Safety Pharmacology, Abbvie, North Chicago, IL 60064, USA., Winters BR; Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA 94080, USA., Authier S; Charles River Laboratories, Laval, QC H7V 4B3, Canada., Curtis MJ; Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London SE17EH, UK.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2023 Sep-Oct; Vol. 123, pp. 107300. Date of Electronic Publication: 2023 Jul 29.
Autor:
Rossman EI; GSK, Nonclinical Safety, Safety Pharmacology, Collegeville, PA, USA. Electronic address: eric.i.rossman@gsk.com., Wisialowski TA; Pfizer Worldwide Research Development and Medical, Safety Pharmacology, Groton, CT, USA., Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA., Valentin JP; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium., Rolf MG; AstraZeneca, Clinical Pharmacology & Safety Sciences, R&D, Gothenburg, Sweden., Roche BM; Charles River Laboratories, Global Safety Pharmacology, Ashland, OH, USA., Riley S; Pfizer Worldwide Research Development and Medical, Clinical Pharmacology, Groton, CT, USA., Pugsley MK; Cytokinetics, Toxicology, South San Francisco, CA, USA., Nichols J; Labcorp Early Development Laboratories Inc., Madison, WI, USA., Li D; Pfizer Global Product Development, Global Biometrics & Data Management, Groton, CT, USA., Leishman DJ; Eli Lilly and Company, Indianapolis, IN, USA., Kleiman RB; Clario, Philadelphia, PA, USA., Greiter-Wilke A; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Gintant GA; NuPharma Consulting, LLC, USA., Engwall MJ; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA., Delaunois A; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium., Authier S; Charles River Laboratories, Laval, QC, Canada.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2023 Sep-Oct; Vol. 123, pp. 107270. Date of Electronic Publication: 2023 May 08.